Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Veradigm (MDRX)
OTHER OTC:MDRX
Holding MDRX?
Track your performance easily
MDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.01 - $11.80
Previous Close$9.5
Volume161.34K
Average Volume (3M)341.35K
Market Cap
$1.61B
Enterprise Value$1.34B
Total Cash (Recent Filing)$492.60M
Total Debt (Recent Filing)$218.81M
Price to Earnings (P/E)―
Beta0.36
Next Earnings
Feb 22, 2024EPS Estimate
$0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding109,259,776
10 Day Avg. Volume390,109
30 Day Avg. Volume341,350
Standard Deviation0.13
R-Squared0.06
Alpha0.00016
Financial Highlights & Ratios
Price to Book (P/B)0.88
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)9.20
P/FCF Ratio12.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.60
Enterprise Value/Gross Profit2.16
Enterprise Value/Ebitda6.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Veradigm News
PremiumCompany Announcements
Veradigm Ends Credit Agreement with JPMorgan Chase
PremiumCompany Announcements
Veradigm Explores Strategic Options, Reaffirms 2024 Outlook
Ownership Overview
7.57% Insiders
1.99% Mutual Funds
3.57% Other Institutional Investors
86.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MDRX FAQ
What was Veradigm’s price range in the past 12 months?
Veradigm lowest stock price was $5.01 and its highest was $11.80 in the past 12 months.
What is Veradigm’s market cap?
Currently, no data Available
When is Veradigm’s upcoming earnings report date?
Veradigm’s upcoming earnings report date is Feb 22, 2024 which is 304 days ago.
How were Veradigm’s earnings last quarter?
Veradigm released its earnings results on Nov 02, 2023. The company reported $0.215 earnings per share for the quarter, the consensus estimate of $0.215 by $0.
Is Veradigm overvalued?
According to Wall Street analysts Veradigm’s price is currently Overvalued.
Does Veradigm pay dividends?
Veradigm does not currently pay dividends.
What is Veradigm’s EPS estimate?
Veradigm’s EPS estimate is $0.34.
How many shares outstanding does Veradigm have?
Veradigm has 169,549,270 shares outstanding.
What happened to Veradigm’s price movement after its last earnings report?
Veradigm reported an EPS of $0.215 in its last earnings report, expectations of $0.215. Following the earnings report the stock price went up 1.329%.
Which hedge fund is a major shareholder of Veradigm?
Among the largest hedge funds holding Veradigm’s share is Silver Point Capital L.P.. It holds Veradigm’s shares valued at N/A.
---
Veradigm Stock Smart Score
Company Description
Veradigm
Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, connectivity, information solutions, and related professional services. It operates through the following segments: Clinical and Financial Solutions; Population Health; and Netsmart. The Clinical and Financial Solutions segment involves in the sale of clinical software applications and financial and information solutions. The Population Health segment offers health management and coordinated care solutions. The Netsmart segment operates in the home care and behavioral healthcare information technology field throughout the United States. The company was founded in 1986 and is headquartered in Chicago, IL.
---
MDRX Earnings Call
Q3 2022
0:00 / 0:00
---
MDRX Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering MDRX
1 Year
1 Year Success Rate
18/26 ratings generated profit
1 Year Average Return
+24.00%
reiterated a buy rating 9 months ago
Copying Sean Dodge's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +24.00% per trade.
---